Baseline characteristics and the effect of selenium supplementation on cancer incidence in a randomized clinical trial: A summary report of the Nutritional Prevention of Cancer Trial

Cancer Epidemiology Biomarkers and Prevention

Volumn 11, Issue 7, 2002, Pages 630-639

  Duffield Lillico, Anna J ^a   Reid, Mary E ^a,b   Turnbull, Bruce W ^c   Combs, Gerald F ^d   Slate, Elizabeth H ^e   Fischbach, Lori A ^f   Marshall, James R ^a,b   Clark, Larry C ^a  

^a UNIVERSITY OF ARIZONA   (United States)

^b UNIVERSITY OF ARIZONA   (United States)

^c Cornell University   (United States)

^d Department of Obstetrics Gynecology   (United States)

^e MEDICAL UNIVERSITY OF SOUTH CAROLINA   (United States)

^f UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; SELENIUM;

ADULT; AGE; AGED; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER PREVENTION; CANCER RECURRENCE; CLINICAL TRIAL; COLORECTAL CANCER; CONFIDENCE INTERVAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIET SUPPLEMENTATION; DOUBLE BLIND PROCEDURE; DRUG BLOOD LEVEL; FEMALE; GENDER; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROSTATE CANCER; RANDOMIZED CONTROLLED TRIAL; SKIN CANCER; SMOKING; UNITED STATES;

AGE DISTRIBUTION; AGED; CONFIDENCE INTERVALS; DIETARY SUPPLEMENTS; DOUBLE-BLIND METHOD; FOLLOW-UP STUDIES; HUMANS; INCIDENCE; MALE; MIDDLE AGED; PROBABILITY; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; REFERENCE VALUES; RISK FACTORS; SELENIUM; SKIN NEOPLASMS; TREATMENT OUTCOME;

EID: 0036317615     PISSN: 10559965     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (91)

1. Effects of selenium supplementation for cancer prevention in patients with carcinoma of the skin. A randomized controlled trial
2. Plasma selenium and skin neoplasms: A case-control study
3. Modification of the official fluorometric method for selenium in plants
4. Reporting the accuracy of biochemical measurements for epidemiologic and nutrition studies
5. Group sequential designs for monitoring survival probabilities
6. Decreased incidence of prostate cancer with selenium supplementation: Results of a double-blind cancer prevention trial
7. Possible protective effect of selenium against human cancer
8. The epidemiology of selenium and cancer
9. Regional variation of cancer mortality incidence and its relation to selenium levels in China
10. Cancer mortality correlation studies. II. Regional associations of mortalities with the consumptions of foods and other commodities
11. Prediagnostic serum selenium and risk of cancer
12. Association between serum selenium and the risk of cancer
13. Risk of cancer in relation to serum concentrations of selenium and vitamins A and E: Matched case-control analysis of prospective data
14. Low plasma selenium as a risk factor for cancer death in middle-aged men
15. The Linxian trials: Mortality rates by vitamin-mineral intervention group
16. Levels of selenium in plasma and glutathione peroxidase in erythrocytes in patients with prostate cancer or benign hyperplasia
17. Serum selenium and subsequent risk of prostate cancer
18. Study of prediagnostic selenium level in toenails and the risk of advanced prostate cancer
19. Decreased selenium concentration and glutathione peroxidase activity in blood and increase of these parameters in malignant tissue of lung cancer patients
20. Is low selenium status a risk factor for lung cancer?
21. A prospective cohort study on selenium status and the risk of lung cancer
22. A case-control study on selenium, zinc, and copper in plasma and hair of subjects affected by breast and lung cancer
23. Serum levels of selenium and retinol and the subsequent risk of cancer
24. Br, Rb, Zn, Fe, Se and K in blood of colorectal patients by INAA and PIXE
25. A case-control study of toenail selenium and cancer of the breast, colon, and prostate
26. Serum selenium and colonic neoplastic risk
27. Blood levels of natural antioxidants in gastric and colorectal precancerous lesions and cancers in Slovakia
28. Serum selenium and subsequent risk of cancer among Finnish men and women
29. Is serum selenium a risk factor for cancer in men only?
30. The association between baseline vitamin E, selenium, and prostate cancer in the α-Tocopherol, β-Carotene Cancer Prevention Study
31. Association between α-tocopherol, γ-tocopherol, selenium, and subsequent prostate cancer
32. Serum selenium and the risk of cancer, by specific sites: Case-control analysis of prospective data
33. Prediagnostic serum selenium and zinc levels and subsequent risk of lung and stomach cancer in Japan
34. The risk of developing lung cancer associated with antioxidants in the blood: Ascorbic acid, carotenoids, α-tocopherol, selenium, and total peroxyl radical absorbing capacity
35. Serologic precursors of cancer. I. Prediagnostic serum nutrients and colon cancer risk
36. Selenium, retinol, retinol-binding protein, and uric acid. Associations with cancer mortality in a population-based prospective case-control study
37. Serum tocopherols, selenium and lung cancer risk among tin miners in China
38. A prospective cohort study on toenail selenium levels and risk of gastrointestinal cancer
39. Reduced risk of colon cancer with high intake of vitamin E: The Iowa Women's Health Study
40. Cancer mortality in a residential cohort exposed to environmental selenium through drinking water
41. Prospective study of toenail selenium levels and cancer among women
42. Prediagnostic serum selenium in a case-control study of thyroid cancer
43. Serologic precursors of cancer: Serum micronutrients and the subsequent risk of pancreatic cancer
44. Prospective study of serum selenium levels and incident esophageal and gastric cancers
45. Excess melanoma incidence in a cohort exposed to high levels of environmental selenium
46. Serum selenium levels in patients with malignant melanoma
47. Serum micronutrients and risk of cancers of low incidence in Finland
48. Serological precursors of cancer: Malignant melanoma, basal and squamous cell skin cancer, and prediagnostic levels of retinol, β-carotene, lycopene, α-tocopherol, and selenium
49. Selenium, lycopene, α-tocopherol, β-carotene, retinol, and subsequent bladder cancer
50. Serum micronutrients and the subsequent risk of oral and pharyngeal cancer
51. Laryngeal cancer and blood selenium levels
52. A case-control study of oral cancer and pre-diagnostic concentrations of selenium and zinc in nail tissue
53. Lipid peroxidation and antioxidant system in the blood of patients with Hodgkin's disease
54. A prospective study of selenium status and breast cancer risk
55. Selenium and the risk of postmenopausal breast cancer in the DOM cohort
56. Selenium in human mammary carcinogenesis: A case-referent study
57. Tissue antioxidants and postmenopausal breast cancer: The European Community Multicentre Study on Antioxidants. Myocardial Infarction, and Cancer of the Breast (EURAMIC)
58. Selenium in diet, blood, and toenails in relation to breast cancer: A case-control study
59. Relationships of serum androgens and estrogens to prostate cancer risk: Results from a prospective study in Finland
60. Selenium levels in nails of premenopausal breast cancer patients assessed prediagnostically in a cohort-nested case-referent study among women screened in the DOM project
61. Antioxidants in female breast cancer patients
62. Thyroid hormones and selenium status in breast cancer
63. Toenail selenium and breast cancer-a case-control study in Finland
64. Toenail selenium levels and the risk of breast cancer
65. Levels of selenium in plasma and glutathione peroxidase in erythrocytes and the risk of breast cancer. A case-control study
66. Plasma selenium level in cancer patients
67. Serum vitamins A and E, β-carotene, and selenium in patients with breast cancer
68. Selenium and cancer
69. Serum retinol, β-carotene, vitamin E, and selenium as related to subsequent cancer of specific sites
70. The protective role of selenium on genetic damage and on cancer
71. Urinary selenium status of healthy people
72. Selenium metabolism in humans differs by gender: Results from a stable isotope tracer study
73. Primary prevention, smoking, and smoking cessation: Implications for future trends in lung cancer prevention
74. Chemoprevention of respiratory tract cancer
75. The effect of vitamin E and β-carotene on the incidence of lung cancer and other cancers in male smokers
76. The α-tocopherol, β-carotene cancer prevention study in Finland
77. Lack of effect of long-term supplementation with β-carotene on the incidence of malignant neoplasms and cardiovascular disease
78. β-Carotene supplementation for patients with low baseline levels and decreased risks of total and prostate carcinoma
79. Antioxidant nutrients and pulmonary function: The Third National Health and Nutrition Examination Survey (NHANES III)
80. Selenium and cancer prevention. Promising results indicate further trials required
81. Seleno-protein P concentration in plasma is an index of selenium status in selenium-deficient and selenium-supplemented Chinese subjects
82. An estimation of selenium requirements for New Zealanders
83. Selenium status and its correlates in a British national diet and nutrition survey: People aged 65 years and over
84. Glutathione peroxidase codon 198 polymorphism variant increases lung cancer risk
85. Phenotype determination of a common Pro-Leu polymorphism in human glutathione peroxidase 1
86. Structure-expression relationships of the 15-kDa selenoprotein gene. Possible role of the protein in cancer etiology
87. Randomized, controlled chemoprevention trials in populations at very high risk for prostate cancer: Elevated prostate-specific antigen and high-grade prostatic intraepithelial neoplasia
88. Coltman the next prostate cancer prevention trial